IRIS Accounts Production v26.1.0.640 13014589 Board of Directors 1.10.24 30.9.25 30.9.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh130145892024-09-30130145892025-09-30130145892024-10-012025-09-30130145892023-09-30130145892023-10-012024-09-30130145892024-09-3013014589ns15:EnglandWales2024-10-012025-09-3013014589ns14:PoundSterling2024-10-012025-09-3013014589ns10:Director12024-10-012025-09-3013014589ns10:PrivateLimitedCompanyLtd2024-10-012025-09-3013014589ns10:SmallEntities2024-10-012025-09-3013014589ns10:AuditExempt-NoAccountantsReport2024-10-012025-09-3013014589ns10:SmallCompaniesRegimeForDirectorsReport2024-10-012025-09-3013014589ns10:SmallCompaniesRegimeForAccounts2024-10-012025-09-3013014589ns10:FullAccounts2024-10-012025-09-3013014589ns10:Director22024-10-012025-09-3013014589ns10:Director32024-10-012025-09-3013014589ns10:RegisteredOffice2024-10-012025-09-3013014589ns5:CurrentFinancialInstruments2025-09-3013014589ns5:CurrentFinancialInstruments2024-09-3013014589ns5:ShareCapital2025-09-3013014589ns5:ShareCapital2024-09-3013014589ns5:RetainedEarningsAccumulatedLosses2025-09-3013014589ns5:RetainedEarningsAccumulatedLosses2024-09-3013014589ns5:PlantMachinery2024-10-012025-09-3013014589ns5:FurnitureFittings2024-10-012025-09-3013014589ns5:MotorVehicles2024-10-012025-09-3013014589ns5:PlantMachinery2024-09-3013014589ns5:FurnitureFittings2024-09-3013014589ns5:MotorVehicles2024-09-3013014589ns5:PlantMachinery2025-09-3013014589ns5:FurnitureFittings2025-09-3013014589ns5:MotorVehicles2025-09-3013014589ns5:PlantMachinery2024-09-3013014589ns5:FurnitureFittings2024-09-3013014589ns5:MotorVehicles2024-09-3013014589ns5:WithinOneYearns5:CurrentFinancialInstruments2025-09-3013014589ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-30
REGISTERED NUMBER: 13014589 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2025

FOR

DR JACQUES & SON LIMITED

DR JACQUES & SON LIMITED (REGISTERED NUMBER: 13014589)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


DR JACQUES & SON LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2025







DIRECTORS: Jonathan Jacques
Gillian Margaret Jacques
Gillian Kerr Jacques





REGISTERED OFFICE: Park Farm 86 South Cliff Road
Kirton Lindsey
Gainsborough
United Kingdom
DN21 4HU





REGISTERED NUMBER: 13014589 (England and Wales)





ACCOUNTANTS: Walter Dawson & Son
Chartered Accountants
16 Omega Business Village
Thurston Road
Northallerton
North Yorkshire
DL6 2NJ

DR JACQUES & SON LIMITED (REGISTERED NUMBER: 13014589)

BALANCE SHEET
30 SEPTEMBER 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 565,361 690,424

CURRENT ASSETS
Stocks 217,465 308,257
Debtors 5 1,863 7,126
Prepayments and accrued income 16,412 17,209
Cash at bank 42,235 37,485
277,975 370,077
CREDITORS
Amounts falling due within one year 6 828,564 959,030
NET CURRENT LIABILITIES (550,589 ) (588,953 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

14,772

101,471

PROVISIONS FOR LIABILITIES 113,368 135,018
NET LIABILITIES (98,596 ) (33,547 )

CAPITAL AND RESERVES
Called up share capital 102 102
Profit and loss account (98,698 ) (33,649 )
(98,596 ) (33,547 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DR JACQUES & SON LIMITED (REGISTERED NUMBER: 13014589)

BALANCE SHEET - continued
30 SEPTEMBER 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 May 2026 and were signed on its behalf by:





Jonathan Jacques - Director


DR JACQUES & SON LIMITED (REGISTERED NUMBER: 13014589)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025

1. STATUTORY INFORMATION

Dr Jacques & Son Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance and 20% on reducing balance
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance

Government grants
Grants receivable in relation to profit and loss expenditure are credited to the profit and loss in the year for which they relate.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Biological assets, living plants and animals, are included at the lower of cost and estimated selling price less costs to sell.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


DR JACQUES & SON LIMITED (REGISTERED NUMBER: 13014589)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Income recognition
Income is recognised when goods have been delivered to customers such that the risks and rewards of ownership have transferred to them.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Motor
machinery fittings vehicles Totals
£    £    £    £   
COST
At 1 October 2024 1,433,496 3,781 22,750 1,460,027
Additions 23,832 - - 23,832
At 30 September 2025 1,457,328 3,781 22,750 1,483,859
DEPRECIATION
At 1 October 2024 753,555 1,577 14,471 769,603
Charge for year 146,494 331 2,070 148,895
At 30 September 2025 900,049 1,908 16,541 918,498
NET BOOK VALUE
At 30 September 2025 557,279 1,873 6,209 565,361
At 30 September 2024 679,941 2,204 8,279 690,424

DR JACQUES & SON LIMITED (REGISTERED NUMBER: 13014589)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2025

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 714 4,109
Other debtors 1,149 3,017
1,863 7,126

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 10,643 -
Taxation and social security 747 623
Other creditors 817,174 958,407
828,564 959,030

7. PENSION COMMITMENTS

The company operates a defined contribution pension scheme. The assets of the pension scheme are held separately from those of the company in an independently administered fund. The pension cost represents contributions payable by the company to the fund and amounted to £897 (2024: £nil). Contributions totalling £96 (2024: £nil) were payable to the fund at the year end and are included in creditors.